Top Markets
#1 ADO Protocol ADO Protocol +337.07%
#2 GoPlus Security GoPlus Security +52.45%
#3 Starpower Starpower +36.27%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.77%
#5 GAIB AID GAIB AID +24.67%
#6 The Black Bull The Black Bull +20.07%
#7 Nockchain Nockchain +18.00%
#8 Fake World Assets Fake World Assets +17.14%
#9 DMT-NAT DMT-NAT +14.82%
#10 Casper Network Casper Network +11.97%
Coin of the day
ADO Protocol ADO Protocol
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

CTXR
Peringkat dalam Saham #33050
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm... Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Harga Saham
$0.5625
Kapitalisasi Pasar
$6.29M
Perubahan (1 hari)
-25.56%
Perubahan (1 tahun)
-57.71%
Negara
US
Perdagangan Citius Pharmaceuticals, Inc. (CTXR)

Kategori

Healthcare
Riwayat harga saham Citius Pharmaceuticals, Inc. (CTXR)
Harga penutupan tertinggi: $0.69 pada 2026-08-01

Harga penutupan terendah: $374.99 pada 2014-10-01
Riwayat harga saham Citius Pharmaceuticals, Inc. dari 2014 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -13.64%
2025 -66.66%
2024 -83.96%
2023 -24.36%
2022 -35.96%
2021 48.68%
2020 66.19%
2019 -38.70%
2018 -76.18%
2017 -33.16%
2016 -74.07%
2015 50.02%
2014 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $512.33 30.43%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $980.40 49.95%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $737.94 7.38%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.38 13.33%
BE